Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H27N5O6S |
Molecular Weight | 537.587 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(OC3=CC=CC=C3O)C(OCCO)=NC(=N2)C4=NC=CC=N4
InChI
InChIKey=STTLKJGYAWXIPP-UHFFFAOYSA-N
InChI=1S/C26H27N5O6S/c1-26(2,3)17-9-11-18(12-10-17)38(34,35)31-22-21(37-20-8-5-4-7-19(20)33)25(36-16-15-32)30-24(29-22)23-27-13-6-14-28-23/h4-14,32-33H,15-16H2,1-3H3,(H,29,30,31)
Molecular Formula | C26H27N5O6S |
Molecular Weight | 537.587 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 13:59:12 GMT 2023
by
admin
on
Sat Dec 16 13:59:12 GMT 2023
|
Record UNII |
N373R7N42R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6426756
Created by
admin on Sat Dec 16 13:59:12 GMT 2023 , Edited by admin on Sat Dec 16 13:59:12 GMT 2023
|
PRIMARY | |||
|
DTXSID10423786
Created by
admin on Sat Dec 16 13:59:12 GMT 2023 , Edited by admin on Sat Dec 16 13:59:12 GMT 2023
|
PRIMARY | |||
|
253688-61-8
Created by
admin on Sat Dec 16 13:59:12 GMT 2023 , Edited by admin on Sat Dec 16 13:59:12 GMT 2023
|
PRIMARY | |||
|
N373R7N42R
Created by
admin on Sat Dec 16 13:59:12 GMT 2023 , Edited by admin on Sat Dec 16 13:59:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
Minor metabolite.
MINOR
FECAL; PLASMA; URINE
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||